Zusammenfassung
Der Krankheitswert der peripheren arteriellen Verschlusskrankheit wird immer noch unterschätzt. Selbst bei asymptomatischen Patienten sind die Morbidität und Mortalität deutlich erhöht. Dabei könnte man Betroffene leicht erkennen und gut behandeln. Lesen Sie hier, wie Sie das kardiovaskuläre Risiko Ihrer Patienten nachhaltig senken können.
Literatur
Statistisches Bundesamt (Hrsg.): Gesundheitsbericht für Deutschland. Stuttgart: Metzler-Poeschel 1998
Rümenapf G, Diehm C. Periphere arterielle Verschlusskrankheit. Krankheitswert wird unterschätzt. Dtsch Arztebl 2011;108(40): A 2094
Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33 (Suppl 1):S1–75
Sigvant B, Wiberg-Hedman K, Bergqvist D et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185–1191
Diehm C, Schuster A, Allenberg JR et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172:95–105
Fowkes FG, Rudan D, Rudan I et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382 (9901):1329–1340
Malyar N, Fürstenberg T, Wellmann J et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide populationbased analysis. Eur Heart J 2013;34: 2706–2714
Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008;13:209–515
Meves SH, Diehm C, Berger K et al. Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovasc Dis 2010;29:546–554
Diehm C, Lange S, Darius H et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006;27:1743–1749
Sprengers RW, Janssen KJ, Moll FL et al. Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: data from the prospective Second Manifestations of ARTerial disease (SMART) cohort study. J Vasc Surg 2009;50:1369–1376
Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197–208
Leeper NJ, Myers J, Zhou M et al. Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg 2013;57:728–733
Chen Q, Smith CY, Bailey KR, Wennberg PW, Kullo IJ. Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc 2013;2(5):e000304
Jones WS, Patel MR, Dai D et al. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J 2013;165:809–815
Diehm C, Darius H, Pittrow D, Allenberg JR. Knöchel-Arm-Index. Ein wegweisender Risikomarker für die hausärztliche Praxis. Dtsch Arztebl 2005;102:A2310–2313 [Heft 34–35]
Deutsche Gesellschaft für Angiologie. Gesellschaft für Gefäßmedizin. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). AWMF-Register Nr. 065/003. Stand 27. April 2009
Aboyans V, Criqui MH, Abraham P et al. Measurement and interpretation of the anklebrachial index: a scientific statement from the American Heart Association. Circulation 2012;126:2890–2909
Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery..J Vasc Surg 2011;54:e32–58
Jones WS, Schmit KM, Vemulapalli S et al. Treatment strategies for patients with peripheral artery disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US);2013 May. Report No.: 13-EHC090-EF. AHRQ Comparative Effectiveness Reviews.
World Health Organization. Prevention of Cardiovascular Disease. Pocket guidelines for assessment and management of cardiovascular risk. Geneva, 2007 [http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH.AFR-D-E.rev1.pdf]
Bisdas T, Stachmann A, Weiss K, Borowski M, Grundmann RT, Torsello G Nationales Register für die Erstlinie-Therapiestrategien in Patienten mit kritischer Extremitätenischämie (CRITISCH Register): Studiendesign und aktueller Stand. Gefäßchirurgie 2014, in Druck
Flu HC, Tamsma JT, Lindeman JH, Hamming JF, Lardenoye JH. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 2010;39:70–86
Welten GM, Schouten O, Hoeks SE et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 2008;51:1588–1596
Bhatt DL, Steg PG, Ohman EM et al. REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180–189
Rodriguez F, Cannon CP, Steg PG et al. On behalf of the REACH Registry Investigators. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry. Clin Cardiol. 2013 Oct 25 doi: 10.1002/clc.22217 [Epub ahead of print]
Kumbhani DJ, Steg PG, Cannon CP et al. Reduction of Atherothrombosis for Continued Health Registry Investigators. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med 2013;126:693–700
Jahn R, Diehm C, Lux G et al. Patient Care Evaluation - Peripheral Arterial Disease (PACE-PAD) Study Investigators. Effect of guideline orientation on the outcomes of peripheral arterial disease in primary care. Curr Med Res Opin 2011;27:1183–1190
Hoel AW, Nolan BW, Goodney PP et al. Vascular Study Group of New England. Variation in smoking cessation after vascular operations. J Vasc Surg 2013;57:1338–1344
Author information
Authors and Affiliations
Corresponding author
Additional information
Literatur unter mmw.de
Interessenkonflikt
Der Autor erklärt, dass er sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ. Er legt folgende potenzielle Interessenkonflikte offen: keine.
Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.
Rights and permissions
About this article
Cite this article
Debus, E.S., Torsello, G., Hupp, T. et al. Sind Sie sich dieser Gefahr bewusst?. MMW - Fortschritte der Medizin 156, 56–62 (2014). https://doi.org/10.1007/s15006-014-3095-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-014-3095-6